Uncategorized

Sun Pharma to buy Organon for $11.75B in major portfolio expansion

Published

on

Indian drug giant Sun Pharma has lined up an $11.75 billion acquisition of Organon, a women’s health and biosimilar maker spun out of Merck in 2021.

The all-cash deal came in at $14 per share …

Leave a Reply

Your email address will not be published. Required fields are marked *

Trending

Exit mobile version